The tumor-suppressing activity of chiglitazar is likely attributable to the promotion of endogenous apoptosis in tumor cells by affecting glycolysis and mitochondrial homeostasis and the arrest of the cell cycle progression of tumors through the PPAR-FOXM1 signaling pathway. Here, PPARA is linked to neoplasm.